Upatinib is a prescription drug, and its price varies depending on the drug strength (e.g., 15mg/tablet), region, medical institution, and medical insurance policy. The price should be confirmed with the actual purchasing channel. Before using this medication, it is crucial to strictly follow your doctor's instructions to assess indications and contraindications. Dosage adjustments or combination therapy are not permitted without medical supervision.
Upatinib is primarily used to treat atopic dermatitis, rheumatoid arthritis, and psoriatic arthritis. Specific dosage adjustments must be made based on the patient's age, weight, and liver and kidney function. For example:
The starting dose for patients with atopic dermatitis is usually 15mg once daily. If the effect is insufficient, the dose can be increased to 30mg, but adverse reactions must be monitored.
Patients over 65 years of age or with abnormal liver and kidney function should use this medication with caution, and may require dose adjustments or extended monitoring periods.
Price influencing factors include:
Drug strength: Different strengths (e.g., 15mg or 30mg) have different prices.
Regional differences: Procurement policies and medical insurance reimbursement rates vary by province, affecting the final cost.
Purchase Channels: Prices may differ slightly between hospital pharmacies and regular pharmacies; please purchase medication through legal channels.
Medical Insurance Policy: Some indications may be covered by medical insurance; please consult your local medical insurance department.
Precautions:
Before starting medication, a complete blood count, liver and kidney function test, and infection markers (such as tuberculosis screening) are required. Regular follow-up examinations are necessary during treatment.
This medication is contraindicated in patients with severe infections, active tuberculosis, or severe liver dysfunction. Pregnant and breastfeeding women must strictly adhere to contraception.
Avoid concurrent use with potent CYP3A4 inhibitors (such as ketoconazole) or inducers (such as rifampin), as this may affect efficacy or increase the risk of side effects.
